Last reviewed · How we verify
Recombinant tissue plasminogen activator — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Recombinant tissue plasminogen activator (Recombinant tissue plasminogen activator) — University of Cincinnati.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Recombinant tissue plasminogen activator TARGET | Recombinant tissue plasminogen activator | University of Cincinnati | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Recombinant tissue plasminogen activator CI watch — RSS
- Recombinant tissue plasminogen activator CI watch — Atom
- Recombinant tissue plasminogen activator CI watch — JSON
- Recombinant tissue plasminogen activator alone — RSS
Cite this brief
Drug Landscape (2026). Recombinant tissue plasminogen activator — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-tissue-plasminogen-activator. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab